Smith v. Boehringer Ingelheim Pharmaceuticals, Inc.

ORDER DENYING MOTION TO DISMISS

DAVID R. HERNDON, Chief Judge.

I. INTRODUCTION

The above referenced diversity case is before the Court on the defendant’s, Boehringer Ingelheim Pharmaceuticals, Inc. (“BIPI”), motion to dismiss the plaintiffs claims for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6). For the reasons set forth below, the motion is DENIED.1

*916II. PROCEDURAL BACKGROUND

A. Overview of Related Pradaxa Product Liability Litigation

The above referenced case involves PRADAXA (“Pradaxa”), a prescription pharmaceutical indicated for the prevention of stroke and…